Advocate: Action Plan On Diversifying Clinical Trials Still Too Lax On Industry

FDA Wednesday (Aug. 20) released an action plan to enhance the collection of data for women and demographic subgroups, with the plan coming exactly one year after the agency issued a report suggesting it could improve policies to spur diversity in clinical trials. One women's health advocate said the plan fell short of expectations because it still took no firm action against companies that have been loosely complying with FDA requirements to include women in trials. A report issued by...